Lola Mestre-Trabal
Research Subjects
Lola Mestre-Trabal has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Iban Aldecoa
Department of Pathology, Biomedical Diagnostic Center (CDB), Hospital Clínic de Barcelona, University of Barcelona, 08036 Barcelona, Spain
1 shared publication - Jordi Anton
Hospital Sant Joan de Déu, Universitat de Barcelona Barcelona Spain
1 shared publication - Jordi Yagüe
Department of Immunology, Hospital Clínic de Barcelona, University of Barcelona, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Center of the European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory and Autoimmune Diseases (RITA), Spanish Center of the Centros, Servicios y Unidades de Referencia (CSUR) and Catalan Center of the Xarxa d’Unitats d’Expertesa Clínica (XUEC) for Autoinflammatory Diseases, 08036 Barcelona, Spain
1 shared publication - Josep Maria Grau Masot
Universitat Rovira i Virgili
1 shared publication - José Hernández-Rodríguez
Vasculitis Research Unit, Department of Autoimmune Diseases, Hospital Clinic, Universitat de Barcelona, Institut D'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain
1 shared publication - Julio Bolaños1 shared publication
Latest Publications
- Open Access
- 14 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7630
Characterizing Protracted Febrile Myalgia: Fasciitis and Vasculitis of the Fascia and Muscle as Novel Histopathological Features
Background: Protracted febrile myalgia (PFM) is a rare but severe form of myalgia mainly occurring in pediatric patients with familial Mediterranean fever (FMF). PFM imaging and histopathological data remain scarce. Objectives: A comprehensive clinical, imaging, and histopathological characterization of PFM was performed by retrospectively analyzing a reference center cohort of adult patients with FMF and myalgia, and by a PubMed search of well-described cases with PFM. Results: Among 56 adults with FMF from our center, 32 (57.1%) experienced myalgia, which was generalized in 21 (37.5%) and affected lower limbs in 11 (19.6%) subjects. One (1.8%) patient suffered PFM, mainly affecting calves and Achilles tendons. From our patient’s detailed information and the data from 123 PFM cases reported in the literature, PFM was characterized as usually presenting with fever and severe generalized myalgia, with occasional involvement of lower legs and calves. It is mainly associated (in >90% of cases) with the pathogenic mutation M694V in the MEFV gene. Raised acute phase reactants and normal creatine kinase levels are constant. High glucocorticoid doses are useful in most patients, and sustained colchicine treatment protects from PFM recurrences. MRI may identify a variable degree of muscle inflammatory changes, especially subfascial and myofascial lesions with extension to tendinous structures. PFM histopathology is characterized by T-cell rich inflammatory infiltrates and vasculitis mainly involving the fasciae and myofascial areas, with a lower muscle extent. Conclusions: PFM can occur in children and adults and appears to be clinically manifested as fasciitis/tendinitis caused by a vasculitis of the fasciae rather than a major muscle vasculitis.
- 14 December 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (24) , 7630
Open AccessCharacterizing Protracted Febrile Myalgia: Fasciitis and Vasculitis of the Fascia and Muscle as Novel Histopathological Features
Background: Protracted febrile myalgia (PFM) is a rare but severe form of myalgia mainly occurring in pediatric patients with familial Mediterranean fever (FMF). PFM imaging and histopathological data remain scarce. Objectives: A comprehensive clinical, imaging, and histopathological characterization of PFM was performed by retrospectively analyzing a reference center cohort of adult patients with FMF and myalgia, and by a PubMed search of well-described cases with PFM. Results: Among 56 adults with FMF from our center, 32 (57.1%) experienced myalgia, which was generalized in 21 (37.5%) and affected lower limbs in 11 (19.6%) subjects. One (1.8%) patient suffered PFM, mainly affecting calves and Achilles tendons. From our patient’s detailed information and the data from 123 PFM cases reported in the literature, PFM was characterized as usually presenting with fever and severe generalized myalgia, with occasional involvement of lower legs and calves. It is mainly associated (in >90% of cases) with the pathogenic mutation M694V in the MEFV gene. Raised acute phase reactants and normal creatine kinase levels are constant. High glucocorticoid doses are useful in most patients, and sustained colchicine treatment protects from PFM recurrences. MRI may identify a variable degree of muscle inflammatory changes, especially subfascial and myofascial lesions with extension to tendinous structures. PFM histopathology is characterized by T-cell rich inflammatory infiltrates and vasculitis mainly involving the fasciae and myofascial areas, with a lower muscle extent. Conclusions: PFM can occur in children and adults and appears to be clinically manifested as fasciitis/tendinitis caused by a vasculitis of the fasciae rather than a major muscle vasculitis.